We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 41
Most popular |Most recent

Welcome to the real world: FDA issues long-awaited framework for evaluating the potential use of real-world evidence to support regulatory decisions for drugs and biologics

USA - December 11 2018 On December 6, the Food and Drug Administration (FDA) published a framework for its Real-World Evidence (RWE) Program to strategically leverage...

Heidi Gertner, Robert Church, Susan S. Lee.

CMS proposes requiring drug prices in TV ads

USA - October 23 2018 On October 15, CMS released a proposed rule titled “Medicare and Medicaid Programs: Drug Pricing Transparency,” which would require direct-to-consumer...

Beth L. Roberts, Elizabeth (Beth) Halpern.

A new normal in the pharmaceutical industry: How to fight back when your competitor can't stop fibbing

USA - October 22 2018 Speaking in September at a discussion hosted by the Alliance for a Stronger FDA, Dr. Janet Woodcock provided some candid insight into FDA's...

Susan M. Cook, Heidi Gertner, David M. Fox, Susan S. Lee.

FDA pushes "consumer-friendly" presentation of quantitative data in DTC promotions

USA - October 17 2018 On Tuesday, the Food and Drug Administration (FDA or the agency) published a draft guidance document, "Presenting Quantitative Efficacy and Risk...

Carlo Felizardo, Cailin Lechner, Jane Kalinina, Susan S. Lee.

U.S. Senate passes bill requiring prescription drug ads to include prices

USA - August 28 2018 On Thursday, the U.S. Senate passed (85-7) the fiscal year 2019 minibus appropriations bill (H.R.6157) that would fund the Departments of Labor...

Heidi Gertner, Kathleen A. Peterson, Alice Valder Curran.